Allie Lin
Known title: EVP & General CounselCIK: 0001958035
Associated companies
Transaction History
| BHF | ▼ Sell | Tax Withholding | 3,136 | $188K | 3/2/2026 | View on chart |
| BHF | ▲ Buy | Option Exercise | 7,072 | — | 3/2/2026 | View on chart |
| BHF | ▲ Buy | Grant | 8,974 | $0 | 2/27/2026 | View on chart |
| BHF | ▼ Sell | Tax Withholding | 3,899 | $234K | 2/27/2026 | View on chart |
| BHF | ▲ Buy | Option Exercise | 4,861 | — | 3/1/2025 | View on chart |
| BHF | ▼ Sell | Tax Withholding | 2,150 | $0 | 3/1/2025 | View on chart |
| BHF | ▲ Buy | Grant | 756 | $0 | 2/28/2025 | View on chart |
| BHF | ▼ Sell | Tax Withholding | 371 | $22K | 2/28/2025 | View on chart |
| BHF | ▲ Buy | Option Exercise | 2,559 | — | 3/1/2024 | View on chart |
| BHF | ▼ Sell | Tax Withholding | 1,152 | $53K | 3/1/2024 | View on chart |
| BHF | ▼ Sell | Tax Withholding | 556 | $26K | 3/1/2024 | View on chart |
| BHF | ▲ Buy | Grant | 1,128 | $0 | 2/6/2024 | View on chart |
| BHF | ▲ Buy | Option Exercise | 919 | — | 3/1/2023 | View on chart |
| BHF | ▼ Sell | Tax Withholding | 456 | $27K | 3/1/2023 | View on chart |
| BHF | ▲ Buy | Grant | 15 | $575 | 1/3/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
BHF Analyst Target Cut to $57, Rating Upgrade Amid Market Attention
KBW lowered its price target for BHF to $57, while a rating upgrade is expected after a pending acquisition. The stock has attracted attention following a 24% drop and its inclusion among life‑insurance names sensitive to rising Treasury yields. These developments add context to BHF’s valuation, which sits at a trailing P/E of 3.4 and an analyst average target of $65.
BHF Analyst Target Cut to $57, Rating Upgrade Amid Market Attention. KBW lowered its price target for BHF to $57, while a rating upgrade is expected after a pending acquisition. The stock has attracted attention following a 24% drop and its inclusion among life‑insurance names sensitive to rising Treasury yields. These developments add context to BHF’s valuation, which sits at a trailing P/E of 3.4 and an analyst average target of $65.